The demand for GLP-1 weight-loss drugs is shifting consumer behavior and causing some manufacturers to do an about-face. Professor Mario Macis explores what might happen when results are promising but prices are high and coverage is limited.
Professor Melinda Buntin examines proposed site-neutral payment policies for Medicare, which would pay hospital outpatient departments the same as lower-cost settings for similar services and could dramatically reduce Medicare spending annually.
While the future of artificial superintelligence remains speculative, a Hopkins Business of Health Initiative webinar addresses the need to supersede dangerous possibilities by producing human-centered foundations to advance technology, especially in...
A new study, authored by Carey Business School Professor Tinglong Dai, finds an association between publicly traded companies and recalls of AI-based medical tools.
From piloting ferries at Disney to guiding external affairs at one of the world’s premier children’s hospitals, Grollman’s career has been shaped by a consistent theme: learning from every experience and applying it to build stronger communities.
Illinois just passed a first-in-the-nation law banning AI from delivering mental health therapy services without human oversight, charting a course that will define health care AI regulation for years to come. Professor of Practice Stacey Lee details the...
In this final installment of our five-part series, we look ahead: What can we do to make AI in medicine safe, fair, and sustainable? What policies and practices will ensure AI relieves burdens instead of creating new ones?